Format

Send to

Choose Destination
Cell Stem Cell. 2012 May 4;10(5):492-6. doi: 10.1016/j.stem.2012.04.018.

Promising growth and investment in the cell therapy industry during the first quarter of 2012.

Author information

1
The Advanced Centre for Biochemical Engineering, University College London, Torrington Place, London, WC1E 6BT, UK.

Abstract

In the first quarter of 2012, publicly traded companies in the cell-based therapy industry continued to show promising overall growth. Highlights included $85 million in new capital investment and steady clinical trial progress.

PMID:
22560072
DOI:
10.1016/j.stem.2012.04.018
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center